Unique and Patented Scientific Process
Patented olfaction intellectual property assets and applications developed by a Nobel prize winning team of scientists at Columbia University.
SentiSearch’s patented scientific process allows scientists to uniquely identify both synthetic and natural compounds that are not harmful to humans or animals. Learn more »
SentiSearch’s gene modification process applications focus on the isolation of genes that are ubiquitous among insects. These genes have been identified in various species of insects, including many that have a profound effect on insect’s attraction and repulsion to plant species. Learn more »
In collaboration with Bayer CropScience and nobel-prize winning scientists, SentiSearch is developing solutions which could potentially be effective in the fight to control and eradicate many insect-borne diseases such as malaria and dengue fever. Learn more »
SentiSearch’s licensed scientific process was developed Richard Axel, a Howard Hughes Medical Institute investigator at Columbia University. Axel was awarded the Nobel Prize in Medicine for cloning insects’ olfactory receptors in 2004. Learn more »
SentiSearch’s mission is to fully exploit its exclusive license to certain neurobiology technology granted to the Company by Columbia University and the company’s own patented portfolio. Our proprietary intellectual property is based on the work of Nobel laureate Dr. Richard Axel and uniquely enables us to precisely target and manipulate insect olfactory systems.
One major consequence of our unique capability is the development of insecticides with significantly enhanced effectiveness and specificity, coupled with favorable toxicity profiles. This may have substantial implications for pest control applications, including insect-borne disease control, as well as the insect repellent and agricultural crop protection markets.
Want to know more? Visit About
Patented olfaction intellectual property assets and applications developed by a Nobel prize winning team of scientists at Columbia University.
Innovative solutions to improve the control of malaria and dengue fever in countries where these diseases are endemic in countries around the world.
SentiSearch’s patented scientific process allows scientists to uniquely identify both synthetic and natural compounds that are non-harmful to both humans and animals.
SentiSearch’s gene modification process applications focus on the isolation of genes that are ubiquitous among insects. These genes have a profound effect on insect’s attraction and repulsion to plant species.
MONHEIM, Germany and WEST PALM BEACH, Fla., Nov. 1, 2010 /PRNewswire/ — Bayer CropScience and SentiSearch, Inc. (OTC Bulletin Board: SSRC) have entered into a two-year research agreement to cooperate in the identification of new molecules targeting odorant receptors in Continue reading »
SEATTLE — Five years ago, Bill Gates made an extraordinary offer: he invited the world’s scientists to submit ideas for tackling the biggest problems in global health, including the lack of vaccines for AIDS and malaria, the fact that most vaccines Continue reading »
Five years ago, the Bill & Melinda Gates Foundation awarded $458 million to research projects aimed at creating breakthrough treatments for diseases that cause millions of deaths each year in developing countries. The results are showing promise and leading to Continue reading »
“ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. On August 31, 2010, SentiSearch, Inc. (the “Company”) entered into a Project Research and Product Development Agreement (the “Agreement”) with Bayer CropScience AG (“Bayer”), effective September 15, 2010, pursuant to which the Continue reading »
Want to read more? Visit news